spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

RWS Life Sciences Welcomes New VP of Quality

Clarice Streets joins RWS as VP of Quality for Life Sciences Division

RWS Life Sciences welcomes Clarice Streets, ASQ, CMQ, OE, as Vice President, Global Quality and Process, in charge of the strategic direction and implementation of its Quality system, underlying organizational processes, and change management.

A veteran of life sciences quality management, Ms. Streets brings to RWS an extensive background in quality systems implementation, supplier quality management, root cause analyses, risk management, and FDA and globally regulated life sciences operations.

Managing Director, Sheena Dempsey, describes Streets as “a tremendous asset to our globally expanding company and our clients, who will value her Quality commitment and expertise in life sciences.”

After 16 years in the pharmaceutical industry, Ms. Streets transitioned to the language services sector in life sciences, where she has spent the past five years. She previously served as Director of Quality for LUZ, Inc., which merged with Corporate Translations, Inc., to form RWS Life Sciences in 2017.

About RWS Life Sciences

RWS Life Sciences is the world’s second largest life sciences translation practice and provides a full suite of language services exclusively for the life sciences industry. Visit us online at www.rws.com/lifesciences.

RWS Life Sciences is a division of RWS, the world leader in translation and localization, intellectual property support solutions and life sciences language services.
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Sartorius debuts the Intellicyt iQue3 at CYTO® 2019

Sartorius will be showcasing the latest addition to its cellular analysis portfolio on booth #103 at this year’s CYTO® conference and exhibition, with the launch of the Intellicyt iQue3. The event – which takes place in Vancouver, Canada, from June 22 to 26 – will give delegates the chance to explore a smarter way to perform flow cytometry experiments.
More info >>


White Papers

Sourcing Commercial Drugs for Clinical Trials: US vs. EU Understanding the Differences

Myoderm

Sourcing commercial drugs for clinical trials is a dynamic process. There are many factors to consider: single source or regional sourcing, strategy, price, supply availability, lead times, and documentation are just a few. In the past, there were fewer clinical trials that required commercial drug sourcing, so demand was not as high. Today, the demand for commercial drugs in clinical trials has greatly increased and, as a result, inventory is tighter, orders are monitored more closely by manufacturers, and lead times have increased. This report highlights the key differences in sourcing from the US and EU.
More info >>

Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement